TFRC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.905640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.124180E-01
Normal-vs-Stage2
1.572350E-01
Normal-vs-Stage3
5.883200E-01
Normal-vs-Stage4
9.972100E-02
Stage1-vs-Stage2
7.818400E-01
Stage1-vs-Stage3
2.002800E-01
Stage1-vs-Stage4
3.978000E-01
Stage2-vs-Stage3
2.531000E-01
Stage2-vs-Stage4
1.762220E-01
Stage3-vs-Stage4
1.181380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.931990E-01
Normal-vs-AfricanAmerican
3.837400E-01
Normal-vs-Asian
2.129000E-01
Caucasian-vs-AfricanAmerican
3.619200E-01
Caucasian-vs-Asian
8.846200E-01
AfricanAmerican-vs-Asian
3.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.540000E-01
Normal-vs-Female
1.316440E-01
Male-vs-Female
1.011220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.171600E-01
Normal-vs-Age(41-60Yrs)
1.512400E-01
Normal-vs-Age(61-80Yrs)
2.161600E-01
Normal-vs-Age(81-100Yrs)
1.874400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.614600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.094000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.679400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.500100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.386200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.723800E-01
Normal-vs-Daily Drinker
3.037800E-01
Normal-vs-Weekly Drinker
2.968000E-01
Normal-vs-Occasional Drinker
1.497420E-01
Normal-vs-Social Drinker
1.853220E-01
Non Drinker-vs-Daily Drinker
6.499400E-01
Non Drinker-vs-Weekly Drinker
4.016200E-01
Non Drinker-vs-Occasional Drinker
2.529000E-01
Non Drinker-vs-Social Drinker
3.996800E-01
Daily Drinker-vs-Weekly Drinker
7.028600E-01
Daily Drinker-vs-Occasional Drinker
5.754600E-01
Daily Drinker-vs-Social Drinker
7.425800E-01
Weekly Drinker-vs-Occasional Drinker
9.362800E-01
Weekly Drinker-vs-Social Drinker
9.271000E-01
Occasional Drinker-vs-Social Drinker
8.344600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.917600E-01
Normal-vs-Grade 2
7.813200E-01
Normal-vs-Grade 3
7.894200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.993570E-02
Grade 1-vs-Grade 3
2.328500E-02
Grade 1-vs-Grade 4
6.917600E-01
Grade 2-vs-Grade 3
8.184800E-01
Grade 2-vs-Grade 4
7.813200E-01
Grade 3-vs-Grade 4
7.894200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.910030E-01
Normal-vs-NonDiabetic
2.489400E-01
Diabetic-vs-NonDiabetic
9.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.121800E-02
Normal-vs-NoPancreatitis
2.441400E-01
Pancreatitis-vs-NoPancreatitis
6.724600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.037000E-01
Normal-vs-N1
1.710030E-01
N0-vs-N1
2.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.857600E-01
Normal-vs-TP53-NonMutant
6.558200E-01
TP53-Mutant-vs-TP53-NonMutant
2.969800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
